Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome;Prevalência de doença hepática gordurosa não alcoólica em pacientes com síndrome dos ovários policísticos e sua correlação com síndrome metabólica

Arquivos de Gastroenterologia

Volumn 52, Issue 2, 2015, Pages 117-123

  Romanowski, Mariana Drechmer ^a   Parolin, Monica Beatriz ^a   Freitas, Alexandre C T ^a   Piazza, Mauri J ^a   Basso, Jorgete ^a   Urbanetz, Almir A ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Fatty liver; Metabolic syndrome X; Polycystic ovary syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACANTHOSIS NIGRICANS; ACNE; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTERIAL PRESSURE; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HIRSUTISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BRAZIL; COMPLICATION; EPIDEMIOLOGY; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYCYSTIC OVARY SYNDROME;

ADULT; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYCYSTIC OVARY SYNDROME;

EID: 84930513910     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032015000200008     Document Type: Article

References (28)

1. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2005;90(4):1929-35.
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H F, Futterweit W et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metabol. 2006;91(11):4237-45.
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol metabol. 2004;89(6):2745-9.
4. Biyasheva A, Legro RS, Dunaif A, Urbanek M. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrin Metab. 2009;94(7):2617-25.
5. Brzozowska MM, Ostapowicz G, Weltman, MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol. 2009;24(2):243-7.
6. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the infuence of the criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006;154(1):141-5.
7. Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol. 2007;47(3):412-7.
8. Charatcharoenwitthaya P, Lindor KD. Role of Radiologic Modalities in the Management of Non-alcoholic Steatohepatitis. Clin Liver Dis 2007;11(1): 37-54.
9. Dokras A, Bochner M, Hollinrake E, Marklam S, VanVoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet gynecol 2005;106(1):131-7.
10. Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis. 2007;11(1):75-104
11. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223-6.
12. Ehrmann DA, Barnes RB, Rosenfeld RI, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22(1):141-6.
13. Franks S. Polycystic ovary syndrome. N Eng J Med. 1995;333(13):853-61.
14. Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Fut-terweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol. 2007;5(4):496-501.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Ling and Blood Institute scientific statement. Circulation 2005;112(17):2735-52.
16. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots FR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective sutdy. J Clin Endocrinol Metabol. 1998;83(9):3078-82.
17. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metabol. 1999;84(1):165-9.
18. Marchesini G, Marzocchi R. Metabolic syndrome and NASH. Clin Liver Dis 2007;11(1):105-17.
19. Marcondes JAM, Hayashida SAY, Barcellos CRG, Rocha MP, Maciel GAR, Baracat EC. Metabolic syndrome in womem with polycystic ovary syndrome: prevalence, characteristics and predictors. Arq Bras Endocrinol Metabol. 2007;51(6):972-9.
20. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, et al. Repeatability characteristics of simple indices of insulin resistence: implications for research applications. J Clin Endocrinol Metabol. 2001;86(11):5456-464.
21. Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol. 2008; 61(6):697-706.
22. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11(1):1-16.
23. Pfeifer SM, Kives S. Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin North Am. 2009;36(1):129-52.
24. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
25. Sejti TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metb. 2006;91(5):1741-47.
26. Srikanthan P, Korenman S, Davis S. Polyciystic ovarian syndrome: the next cardiovascular dilemma in women? Endocrinol Metab Clin North Am. 2006;35(3):611-31.
27. The IDF consensus wordlwide definition of metabolic syndrome. Available from: http://www.idf.org.
28. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Hum Reprod. 2004;19:41-7.